Patient Guide: A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 58 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04088396
Status: 🟢 Enrolling Now
Condition: Systemic Juvenile Idiopathic Arthritis
Phase: PHASE3

Where You Can Participate

This study is available at 58 locations across the country.

Top locations include:
  • • Rosario, Santa Fe
  • • SAN M. DE Tucuman, Tucumán
  • • Gent, Oost-Vlaanderen
  • • And 55 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) - Join Clinical Trial NCTNCT04088396

How to Join This Clinical Trial - NCTNCT04088396

Learn how to participate in this PHASE3 trial studying an investigational therapy for Systemic Juvenile Idiopathic Arthritis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Systemic Juvenile Idiopathic Arthritis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Systemic Juvenile Idiopathic Arthritis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04088396 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 58 locations. Find a study site near you:

Clinical Research Site

Rosario, Santa Fe S2000 - Argentina

Status: RECRUITING

Clinical Research Site

SAN M. DE Tucuman, Tucumán T4000AXL - Argentina

Status: RECRUITING

Clinical Research Site

Gent, Oost-Vlaanderen 9000 - Belgium

Status: RECRUITING

Clinical Research Site

Leuven, Vlaams-Brabant 3000 - Belgium

Status: RECRUITING

Clinical Research Site

Porto Alegre, Rio Grande Do Sul 90035-903 - Brazil

Status: RECRUITING

Clinical Research Site

Botucatu, São Paulo 18618-686 - Brazil

Status: RECRUITING

Clinical Research Site

Sao Paulo, São Paulo 05403-000 - Brazil

Status: RECRUITING

Clinical Research Site

São Paulo, 01221-020 - Brazil

Status: RECRUITING

Clinical Research Site

São Paulo, 04022-001 - Brazil

Status: RECRUITING

Clinical Research Site

Brno, Brno-město 613 00 - Czechia

Status: RECRUITING

And 48 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Systemic Juvenile Idiopathic Arthritis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships